Diamens FlexCo is a medical diagnostic company founded in 2024 and headquartered in Linz, Austria, specializing in non-invasive, at-home diagnostic test kits for women's health issues like endometriosis.
Subscribe to see Diamens’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Diamens is a healthtech company headquartered in Austria. Its most recent funding round, Pre-Seed, closed in March 2026. Xcout tracks 9 named people at Diamens, including Marlene Rezk -Füreder (CEO).
3 more named people on record for Diamens, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | Undisclosed | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Diamens's closest competitors — see the full list of competitors and alternatives →
Davion Healthcare Plc designs, develops, manufactures, and globally distributes non-invasive home health tests for the early detection of medical anomalies associated with serious health conditions. The company serves individuals by providing accessible, at-home monitoring solutions such as its lead product, BreastCheck, empowering users to proactively manage their health.
Aspira Women's Health Inc. develops AI-powered diagnostic and testing solutions focused on gynecologic care, specifically for assessing the risk of ovarian cancer and managing pelvic masses. The company provides non-invasive tests such as Ova1Plus and OvaWatch to help healthcare providers improve diagnostic accuracy and personalize treatment plans for patients.
Trimedic is a Canadian company founded in 1986 that specializes in diagnostic testing, women's health, and family planning. The company provides medical devices, supplies, instruments, and over-the-counter products, as well as care for patients with acute and chronic diseases.
Teal Health, Inc. is a women's healthcare company reimagining preventive care by offering at-home self-collected cervical cancer screening solutions.
Nanopath is a biotechnology and diagnostics company developing rapid molecular testing systems, with an emphasis on decentralized point-of-care testing. Its products are intended for healthcare providers and clinical laboratories, including applications in women’s health and infectious-disease diagnosis.
Evvy is a healthtech company offering at-home vaginal microbiome testing that uses metagenomic sequencing to identify microorganisms and provide health insights. It serves people seeking information about vaginal health, including those experiencing recurring symptoms, and connects testing results with educational or clinical support.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.